Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
Be 'active' in the market while NOT being tied to your desk.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| MRNA | Moderna, Inc. | -0.05% | 129.65 | 0.0% | $2878.82m | |
| BNGO | BioNano Genomics, Inc. | 21.30% | 8.43 | 0.0% | $1523.88m | |
| GILD | Gilead Sciences, Inc. | 1.49% | 63.33 | 1.0% | $663.26m | |
| AMGN | Amgen, Inc. | 1.59% | 245.49 | 1.3% | $599.79m | |
| CRSP | CRISPR Therapeutics AG | -4.84% | 199.88 | 0.6% | $544.48m | |
| ALXN | Alexion Pharmaceuticals, Inc. | 0.03% | 156.70 | 2.0% | $501.25m | |
| NVAX | Novavax, Inc. | -1.96% | 127.43 | 92.9% | $480.66m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 0.00% | 517.93 | 2.7% | $480.32m | |
| ILMN | Illumina, Inc. | 1.43% | 376.35 | 3.5% | $384.71m | |
| BIIB | Biogen, Inc. | -1.59% | 275.84 | 1.7% | $366.50m | |
| VRTX | Vertex Pharmaceuticals, Inc. | -0.25% | 225.55 | 1.9% | $350.25m | |
| BNTX | BioNTech SE | -4.03% | 101.59 | 0.0% | $316.33m | |
| SRPT | Sarepta Therapeutics, Inc. | 0.47% | 90.32 | 13.8% | $296.56m | |
| OCGN | Ocugen, Inc. | 1.84% | 2.22 | 0.0% | $276.18m | |
| EDIT | Editas Medicine, Inc. | 0.29% | 76.14 | 7.9% | $256.07m |
Company Profile
Synlogic, Inc. is a clinical-stage biopharmaceutical company. It engages in drug discovery and development of synthetic biotic medicines. The firm focuses on SYNB1020 and SYNB1618, which are orally administered and target hyperammonemia and phenylketonuria. It also works on SYNB1891, an intratumorally administered which treats cancer. The company was founded by Jim Collins and Tim Lu on August 28, 2017, and is headquartered in Cambridge, MA.